PMID- 35371999 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220405 IS - 2234-943X (Print) IS - 2234-943X (Electronic) IS - 2234-943X (Linking) VI - 12 DP - 2022 TI - Comparison of Computed and Acquired DWI in the Assessment of Rectal Cancer: Image Quality and Preoperative Staging. PG - 788731 LID - 10.3389/fonc.2022.788731 [doi] LID - 788731 AB - OBJECTIVE: The aim of the study was to evaluate the computed diffusion-weighted images (DWI) in image quality and diagnostic performance of rectal cancer by comparing with the acquired DWI. METHODS: A total of 103 consecutive patients with primary rectal cancer were enrolled in this study. All patients underwent two DWI sequences, namely, conventional acquisition with b = 0 and 1,000 s/mm(2) (aDWI(b1,000)) and another with b = 0 and 700 s/mm(2) on a 3.0T MR scanner (MAGNETOM Prisma; Siemens Healthcare, Germany). The images (b = 0 and 700 s/mm(2)) were used to compute the diffusion images with b value of 1,000 s/mm(2) (cDWI(b1,000)). Qualitative and quantitative analysis of both computed and acquired DWI images was performed, namely, signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and signal intensity ratio (SIR), and also diagnostic staging performance. Interclass correlation coefficients, weighted kappa coefficient, Friedman test, Wilcoxon paired test, and McNemar or Fisher test were used for repeatability and comparison assessment. RESULTS: Compared with the aDWI(b1,000) images, the cDWI(b1,000) ones exhibited significant higher scores of subjective image quality (all P <0.050). SNR, SIR, and CNR of the cDWI(b1,000) images were superior to those of the aDWI(b1,000) ones (P <0.001). The overall diagnostic accuracy of computed images was higher than that of the aDWI(b1,000) images in T stage (P <0.001), with markedly better sensitivity and specificity in distinguishing T1-2 tumors from the T3-4 ones (P <0.050). CONCLUSION: cDWI(b1,000) images from lower b values might be a useful alternative option and comparable to the acquired DWI, providing better image quality and diagnostic performance in preoperative rectal cancer staging. CI - Copyright (c) 2022 Xia, Wang, Wu, Tan, Fu, Fu, Pan, Zhu, Yan, Shen, Ma and Cai. FAU - Xia, Yihan AU - Xia Y AD - Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University of Medicine, Shanghai, China. FAU - Wang, Lan AU - Wang L AD - Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University of Medicine, Shanghai, China. FAU - Wu, Zhiyuan AU - Wu Z AD - Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University of Medicine, Shanghai, China. FAU - Tan, Jingwen AU - Tan J AD - Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University of Medicine, Shanghai, China. FAU - Fu, Meng AU - Fu M AD - Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University of Medicine, Shanghai, China. FAU - Fu, Caixia AU - Fu C AD - Department of MR Application Development, Siemens Shenzhen Magnetic Resonance Ltd, Shenzhen, China. FAU - Pan, Zilai AU - Pan Z AD - Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University of Medicine, Shanghai, China. FAU - Zhu, Lan AU - Zhu L AD - Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University of Medicine, Shanghai, China. FAU - Yan, Fuhua AU - Yan F AD - Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University of Medicine, Shanghai, China. FAU - Shen, Hailin AU - Shen H AD - Department of Radiology, Suzhou Kowloon Hospital, Shanghai Jiao Tong University of Medicine, Suzhou, China. FAU - Ma, Qianchen AU - Ma Q AD - Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University of Medicine, Shanghai, China. FAU - Cai, Gang AU - Cai G AD - Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiao Tong University of Medicine, Shanghai, China. LA - eng PT - Journal Article DEP - 20220318 PL - Switzerland TA - Front Oncol JT - Frontiers in oncology JID - 101568867 PMC - PMC8971285 OTO - NOTNLM OT - computed diffusion images OT - diagnostic performance OT - diffusion-weighted imaging OT - image quality OT - rectal cancer COIS- The author (CF) is an employee of Siemens Healthcare but did not have control over the data. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/04/05 06:00 MHDA- 2022/04/05 06:01 PMCR- 2022/01/01 CRDT- 2022/04/04 05:32 PHST- 2021/10/03 00:00 [received] PHST- 2022/02/18 00:00 [accepted] PHST- 2022/04/04 05:32 [entrez] PHST- 2022/04/05 06:00 [pubmed] PHST- 2022/04/05 06:01 [medline] PHST- 2022/01/01 00:00 [pmc-release] AID - 10.3389/fonc.2022.788731 [doi] PST - epublish SO - Front Oncol. 2022 Mar 18;12:788731. doi: 10.3389/fonc.2022.788731. eCollection 2022.